IRIS
Russo, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.722
AS - Asia 2.142
EU - Europa 920
SA - Sud America 535
Continente sconosciuto - Info sul continente non disponibili 206
AF - Africa 51
OC - Oceania 1
Totale 6.577
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.627
SG - Singapore 939
IT - Italia 574
CN - Cina 435
BR - Brasile 405
VN - Vietnam 237
IN - India 201
HK - Hong Kong 115
DE - Germania 74
BD - Bangladesh 59
GB - Regno Unito 52
NL - Olanda 52
AR - Argentina 44
CA - Canada 40
FI - Finlandia 38
MX - Messico 31
ID - Indonesia 25
JP - Giappone 23
EC - Ecuador 20
ES - Italia 19
IQ - Iraq 19
ZA - Sudafrica 18
CL - Cile 17
CO - Colombia 15
RU - Federazione Russa 15
PK - Pakistan 14
PL - Polonia 14
CZ - Repubblica Ceca 12
SE - Svezia 12
VE - Venezuela 12
FR - Francia 10
PE - Perù 10
TR - Turchia 10
AE - Emirati Arabi Uniti 8
AT - Austria 8
MA - Marocco 8
PY - Paraguay 8
JM - Giamaica 7
RO - Romania 7
SA - Arabia Saudita 7
SC - Seychelles 7
TH - Thailandia 7
CR - Costa Rica 6
EG - Egitto 6
LT - Lituania 6
UZ - Uzbekistan 6
IL - Israele 5
KE - Kenya 5
NP - Nepal 5
UA - Ucraina 5
JO - Giordania 4
UY - Uruguay 4
BG - Bulgaria 3
BH - Bahrain 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
PH - Filippine 3
RS - Serbia 3
AL - Albania 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BS - Bahamas 2
HN - Honduras 2
IR - Iran 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
PS - Palestinian Territory 2
PT - Portogallo 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
AM - Armenia 1
BE - Belgio 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
DZ - Algeria 1
EE - Estonia 1
GR - Grecia 1
GT - Guatemala 1
HR - Croazia 1
IE - Irlanda 1
KH - Cambogia 1
KI - Kiribati 1
KR - Corea 1
LY - Libia 1
MD - Moldavia 1
MM - Myanmar 1
NI - Nicaragua 1
OM - Oman 1
TG - Togo 1
Totale 6.371
Salva come PNG Salva come JPEG
Città #
San Jose 706
Ashburn 333
Singapore 309
Santa Clara 201
Dallas 187
Bengaluru 165
Hefei 163
Milan 155
Council Bluffs 125
Beijing 111
Hong Kong 105
Ho Chi Minh City 88
Munich 64
Hanoi 55
Princeton 53
Lawrence 50
Phoenix 50
Los Angeles 43
Rome 37
Chicago 33
São Paulo 32
Turku 28
Chandler 27
London 23
New York 23
Wilmington 22
Palermo 21
Naples 18
San Francisco 18
The Dalles 17
Chennai 16
Des Moines 15
Montreal 15
Tokyo 15
Brooklyn 14
Da Nang 14
Columbus 13
Olomouc 12
Warsaw 12
Amsterdam 11
Baghdad 11
Boardman 11
Rio de Janeiro 10
Stockholm 10
Bari 9
Helsinki 9
Johannesburg 9
Atlanta 8
Brasília 8
Cosenza 8
Mexico City 8
Padova 8
Denver 7
Haiphong 7
Hải Dương 7
Joinville 7
Porto Alegre 7
Quito 7
Rende 7
Belo Horizonte 6
Boston 6
Buffalo 6
Dhaka 6
Guayaquil 6
Jakarta 6
Maryland Heights 6
Orem 6
Salt Lake City 6
Salvador 6
Santiago 6
Biên Hòa 5
Bologna 5
Caracas 5
Catanzaro 5
Lima 5
Manchester 5
Nairobi 5
Norwalk 5
Philadelphia 5
San José 5
Tashkent 5
Thái Bình 5
Urbisaglia 5
Amman 4
Ankara 4
Aversa 4
Bogotá 4
Cairo 4
Can Tho 4
Catania 4
Charlotte 4
Curitiba 4
Florence 4
Guarulhos 4
Itajaí 4
Kingston 4
Lecce 4
Medellín 4
Miami 4
Pune 4
Totale 3.756
Salva come PNG Salva come JPEG
Nome #
The Role of Gut Microbiota in the Clinical Outcome of Septic Patients: State of the Art and Future Perspectives 100
The spike-specific TCRβ repertoire shows distinct features in unvaccinated or vaccinated patients with SARS-CoV-2 infection 85
Persistence of SARS-CoV-2 infection and viral intra- and inter-host evolution in COVID-19 hospitalized patients 80
Multidisciplinary approach to a septic COVID-19 patient undergoing veno-venous extracorporeal membrane oxygenation and receiving thoracic surgery 80
Clinical characteristics, therapy and outcome of bloodstream infections caused by vancomycin-resistant enterococci: a multicentre clinical experience 73
EFFICACY OF CEFIDEROCOL- VERSUS COLISTIN-CONTAINING REGIMEN FOR TREATMENT OF BACTEREMIC VENTILATOR-ASSOCIATED PNEUMONIA CAUSED BY CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII IN COVID-19 PATIENTS 73
Severe Hemodynamic Instability in a Young Pregnant Woman with Massive Pericardial Effusion and Pulmonary Embolism Secondary to Primary Mediastinal Non-Hodgkin's Lymphoma 70
SARS CoV-2 spike protein-guided exosome isolation facilitates detection of potential miRNA biomarkers in COVID-19 infections 70
The role of Gram-negative bacteria in skin and soft tissue infections 67
Ceftazidime-avibactam use for klebsiella pneumoniae carbapenemase-producing k. pneumoniae infections: A retrospective observational multicenter study 65
Touching Base with Some Mediterranean Diseases of Interest from Paradigmatic Cases at the “Magna Graecia” University Unit of Infectious Diseases: A Didascalic Review 63
Role of the T2Dx magnetic resonance assay in patients with suspected bloodstream infection: a single-centre real-world experience 63
Post-traumatic stress symptoms in healthcare workers dealing with the covid-19 pandemic: A systematic review 62
Efficacy of a Fosfomycin-Containing Regimen for Treatment of Severe Pneumonia Caused by Multidrug-Resistant Acinetobacter baumannii: A Prospective, Observational Study 62
Is the Pendulum of Antimicrobial Drug Resistance Swinging Back after COVID-19? 61
Dynamics of Viral Infection and Evolution of SARS-CoV-2 Variants in the Calabria Area of Southern Italy 61
Antibiotic Treatment of Carbapenem-Resistant Acinetobacter baumannii Infections in View of the Newly Developed β-Lactams: A Narrative Review of the Existing Evidence 59
Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections 59
Impact of Multiplex PCR on Diagnosis of Bacterial and Fungal Infections and Choice of Appropriate Antimicrobial Therapy. 57
Early administration of tofacitinib in COVID-19 pneumonitis: An open randomised controlled trial 56
Spike-specific T-cell responses in patients with COVID-19 successfully treated with neutralizing monoclonal antibodies against SARS-CoV-2 56
A systematic review on antibiotic therapy of cutaneous bacillary angiomatosis not related to major immunocompromising conditions: from pathogenesis to treatment 56
The role of teicoplanin in the treatment of SARS-CoV-2 infection: A retrospective study in critically ill COVID-19 patients (Tei-COVID study) 55
Tuberculosis and drug resistance in a region of Southern Italy among native and foreign-born populations: A twelve-year province-based study 53
Lights and Shadows of Long COVID: Are Latent Infections the Real Hidden Enemy? 53
Intravenous fosfomycin for treatment of severe infections caused by carbapenem-resistant Acinetobacter baumannii: A multi-centre clinical experience 52
A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae 52
Lights and Shadows of Sepsis Management: Challenges and Future Perspectives 51
Bacterial Ventilator-Associated Pneumonia in COVID-19 Patients: Data from the Second and Third Waves of the Pandemic 51
Interleukin-62/lymphocyte as a proposed predictive index for COVID-19 patients treated with monoclonal antibodies 50
Incipient tuberculosis: a comprehensive overview 50
Preoperative right ventricular strain as an early predictor of perioperative cardiac failure in patients undergoing mitral surgery: An exploratory study 50
COVID-19-associated pulmonary aspergillosis in intensive care unit: A real-life experience 50
Ceftaroline for severe community-acquired pneumonia: A real-world two-centre experience in Italy and Spain 49
Clinical Characteristics and Outcome of Hospitalized COVID-19 Patients Treated with Standard Dose of Dexamethasone or High Dose of Methylprednisolone 49
Evolution of in-hospital patient characteristics and predictors of death in the COVID-19 pandemic across four waves: are they moving targets with implications for patient care? 48
Microbiological and Clinical Findings of SARS-CoV-2 Infection after 2 Years of Pandemic: From Lung to Gut Microbiota 48
INTERLEUKIN-62/LYMPHOCYTE AS A PROPOSED PREDICTIVE INDEX FOR COVID-19 PATIENTS TREATED WITH MONOCLONAL ANTIBODIES 47
Early initiation of combined therapy in severely immunocompromised patients with COVID-19: a retrospective cohort study 47
Clinical features, therapy and outcome of patients hospitalized or not for nursing-home acquired pneumonia 47
Publisher Correction: Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study 46
Surgical Versus Conservative Treatment of Post-Sternotomy Mediastinitis: Clinical Characteristics, Microbiology, and Outcomes from a 10-Year Cohort 46
Recent molecules in the treatment of severe infections caused by ESBL-producing bacteria 46
Role of oral nystatin prophylaxis in cardiac surgery with prolongedextracorporeal circulation 46
A hypothesis-generating study of the combination of aspirin plus macrolides in patients with severe community-acquired pneumonia 46
A multinational, preregistered cohort study of β-lactam/β-lactamase inhibitor combinations for treatment of bloodstream infections due to extended-spectrum-β-lactamase-producing enterobacteriaceae 46
In vitro Activity of Cefiderocol Against Carbapenem-Resistant Acinetobacter baumannii Clinical Isolates: a Single Center Experience 44
Publisher Correction: Lessons learned and implications of early therapies for coronavirus disease in a territorial service centre in the Calabria region: a retrospective study (BMC Infectious Diseases, (2022), 22, 1, (793), 10.1186/s12879-022-07774-9) 44
Intravenous Fosfomycin for Systemic Multidrug-Resistant Pseudomonas aeruginosa Infections 44
Risk factors for the development of hospital-acquired pneumonia in patients with carbapenem-resistant Acinetobacter baumannii respiratory colonization and the role of multisite colonization: a multicenter retrospective study. 44
Role of Low-Molecular-Weight Heparin in Hospitalized Patients with Severe Acute Respiratory Syndrome Coronavirus 2 Pneumonia: A Prospective Observational Study 44
Early antibiotic treatment in emergency department: the critical balance 44
New advances in management and treatment of multidrug-resistant Klebsiella pneumoniae 43
Clinical features and outcome of difficult-to-treat infections in a high-intensity medical care ward 43
Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: Clinical features, therapy and outcome from a multicenter study 43
Inhaled Liposomal Antimicrobial Delivery in Lung Infections 42
Comparison of septic shock due to multidrug-resistant acinetobacter baumannii or klebsiella pneumoniae carbapenemase-producing k. Pneumoniae in intensive care unit patients 42
Candidemia in Patients with Body Temperature Below 37°C and Admitted to Internal Medicine Wards: Assessment of Risk Factors 42
A case of Lactobacillus casei bacteraemia associated with aortic dissection: Is there a link? 42
Procalcitonin in daily clinical practice: an evergreen tool also during a pandemic 41
Effect of n-acetylcysteine administration on 30-day mortality in critically ill patients with septic shock caused by carbapenem-resistant klebsiella pneumoniae and acinetobacter baumannii: A retrospective case-control study 41
Candida endocarditis: systematic literature review from 1997 to 2014 and analysis of 29 cases from the Italian Study of Endocarditis 41
Covid-19 sequelae in working age patients: A systematic review 41
From Spores to Solutions: A Comprehensive Narrative Review on Mucormycosis 40
OMIC INSIGHTS INTO VARIOUS CEFTAZIDIME-AVIBACTAM-RESISTANT KLEBSIELLA PNEUMONIAE ISOLATES FROM TWO SOUTHERN ITALIAN REGIONS 40
Is NOX2 upregulation implicated in myocardial injury in patients with pneumonia? 40
Intravenous Fosfomycin: The Underdog Player in the Treatment of Carbapenem-resistant Acinetobacter baumannii Infections 39
Management of intra-abdominal infections: recommendations by the Italian council for the optimization of antimicrobial use 39
Assessment of risk factors for candidemia in non-neutropenic patients hospitalized in Internal Medicine wards: A multicenter study 38
Role of procalcitonin in bacteremic patients and its potential use in predicting infection etiology 38
Daptomycin serum levels in critical patients undergoing continuous renal replacement 38
Chronic Suppressive Antibiotic Treatment for Staphylococcal Bone and Joint Implant–Related Infections 38
Multidrug-resistant klebsiella pneumoniae: Challenges for treatment, prevention and infection control 37
Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia 37
High Incidence of Candidemia in Critically Ill COVID-19 Patients Supported by Veno-Venous Extracorporeal Membrane Oxygenation: A Retrospective Study 36
New advances in management and treatment of cardiac implantable electronic devices infections 36
SARS-CoV-2 pandemic, influenza, and influenza-like illness epidemics: Allies or enemies? 36
Candidemia subsequent to severe infection due to Clostridium difficile: Is there a link? 36
Efficacy of remdesivir-containing therapy in hospitalized COVID-19 patients: A prospective clinical experience 36
Severe respiratory failure in an immunocompetent host with invasive pulmonary aspergillosis and h1n1 influenza 36
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 35
Circulation of a Unique Klebsiella pneumoniae Clone, ST147 NDM-1/OXA-48, in Two Diverse Hospitals in Calabria (Italy) 35
COVID-19 and kidney transplantation: an Italian Survey and Consensus 35
Role of new antibiotics in extended-spectrum β-lactamase-, AmpC- infections 35
Real-world corticosteroid use in severe pneumonia: a propensity-score-matched study 35
Pulmonary Aspergillosis: An Evolving Challenge for Diagnosis and Treatment 35
Viral community acquired pneumonia at the emergency department: Report from the pre COVID-19 age 35
Time to Effective Therapy Is an Important Determinant of Survival in Bloodstream Infections Caused by Vancomycin-Resistant Enterococcus spp 34
Effect of piperacillin-tazobactam vs meropenem on 30-day mortality for patients with e coli or Klebsiella pneumoniae bloodstream infection and ceftriaxone resistance 34
Antimicrobial resistance and treatment: an unmet clinical safety need 33
CAP and HCAP are different? An unresolved question 33
Targeting Microbiome: An Alternative Strategy for Fighting SARS-CoV-2 Infection 33
Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: A multinational pre-registered cohort study 33
Broadly reactive human CD4+ T cells against Enterobacteriaceae are found in the naïve repertoire and are clonally expanded in the memory repertoire 33
Efficacy of daptomycin-containing regimen for treatment of staphylococcal or enterococcal vertebral osteomyelitis: A prospective clinical experience 33
Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission 33
Ceftazidime-Avibactam for the Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections in Patients With Liver Cirrhosis 33
Predictors of mortality in nursing-home residents with pneumonia: a multicentre study 32
Vertebral osteomyelitis caused by vancomycin-resistant Enterococcus spp.: a case series 32
Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae 32
Totale 4.694
Salva come PNG Salva come JPEG
Categoria #
all - tutte 58.522
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 58.522
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022142 0 0 0 0 0 0 48 25 25 19 25 0
2022/2023336 104 7 15 12 15 2 3 20 109 10 28 11
2023/2024327 45 38 17 32 34 40 26 11 8 14 36 26
2024/20251.500 231 9 25 47 105 213 45 57 212 77 172 307
2025/20263.863 147 526 386 590 425 160 465 184 456 277 178 69
2026/2027409 53 200 156 0 0 0 0 0 0 0 0 0
Totale 6.577